{"version":"1.0","type":"link","title":"Sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2-negative breast cancer: a single-center retrospective analysis.","author_name":"Tam G 외","author_url":"https://prs-insight.online/author/Tam%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76264","thumbnail_width":1200,"thumbnail_height":630}